NCT06716762

Brief Summary

This is a retrospective cohort study designed to compare the outcomes of open surgery versus laparoscopic surgery in pediatric patients diagnosed with congenital choledochal cyst (CCC). The study includes children who underwent surgery at Guangdong Medical University Affiliated Hospital and Guangzhou Women and Children's Medical Center between January 1, 2010, and September 1, 2024. The aim of this study is to evaluate and compare the surgical outcomes, including surgery duration, intraoperative blood loss, hospital stay, and postoperative complications (e.g., bile leakage and intestinal obstruction), between the two surgical approaches. The data collected from the patient records will be analyzed to identify factors influencing surgical outcomes and to guide future treatment decisions for CCC in pediatric patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
14.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

November 27, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 4, 2024

Completed
Last Updated

December 4, 2024

Status Verified

December 1, 2024

Enrollment Period

14.7 years

First QC Date

November 27, 2024

Last Update Submit

December 2, 2024

Conditions

Keywords

Congenital Choledochal CysNetwork Meta-analysisRobotic-assisted SurgeryLaparoscopic SurgeryPediatric Surgical Outcomes

Outcome Measures

Primary Outcomes (4)

  • Surgery Duration

    The time required to complete the surgical procedure, from the initial incision to the closure of the surgical site. This is measured in minutes and compared between the open surgery and laparoscopic surgery groups

    Measured intraoperatively, from the initial incision to the closure of the surgical site, at the end of the surgery.

  • Postoperative Complications

    The occurrence of postoperative complications, specifically bile leakage and intestinal obstruction, in patients undergoing either open or laparoscopic surgery. This is measured as a binary outcome (yes/no) and will be compared between the two groups.

    30 days post-surgery (for short-term complications)

  • Intraoperative Blood Loss

    The total amount of blood lost during the surgical procedure, measured in milliliters (mL). This will be compared between the two surgical groups (open surgery and laparoscopic surgery).

    Measured intraoperatively, during the surgery, from the initial incision to the closure of the surgical site.

  • Hospital Stay

    The total number of days the patient stays in the hospital post-surgery until discharge. This is compared between the open surgery and laparoscopic surgery groups.

    Measured from the day of surgery to discharge, assessed over the duration of hospital stay, up to 30 days post-surgery.

Study Arms (2)

Open Surgery Group, OSG

This group consists of pediatric patients diagnosed with congenital choledochal cyst (CCC) who underwent open surgery, which involved open cyst excision and Roux-en-Y hepaticojejunostomy. A total of 60 patients were assigned to this group.

Procedure: Open Surgery

Laparoscopic Surgery Group, LSG

This group includes pediatric patients diagnosed with CCC who underwent laparoscopic surgery, which involved laparoscopic cyst excision and Roux-en-Y hepaticojejunostomy. A total of 12 patients were assigned to this group.

Procedure: Laparoscopic Surgery

Interventions

Open SurgeryPROCEDURE

Open cyst excision and Roux-en-Y hepaticojejunostomy performed through a 10 cm incision

Open Surgery Group, OSG

Laparoscopic cyst excision and Roux-en-Y hepaticojejunostomy performed through small incisions with a laparoscope

Laparoscopic Surgery Group, LSG

Eligibility Criteria

Age0 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of pediatric patients diagnosed with congenital choledochal cyst (CCC) who underwent surgical treatment at Guangdong Medical University Affiliated Hospital and Guangzhou Women and Children's Medical Center between January 1, 2010, and September 1, 2024. The total number of patients included in this study is 72, with 60 patients assigned to the open surgery group (OSG) and 12 patients assigned to the laparoscopic surgery group (LSG).

You may qualify if:

  • Pediatric patients diagnosed with congenital choledochal cyst based on preoperative imaging (e.g., ultrasound, computed tomography(CT), or magnetic resonance cholangiopancreatography(MRCP)).
  • Patients who underwent either open surgery (open cyst excision and Roux-en-Y hepaticojejunostomy) or laparoscopic surgery (laparoscopic cyst excision and Roux-en-Y hepaticojejunostomy) for the treatment of congenital choledochal cyst.
  • Informed consent for follow-up obtained from the patient's family or legal guardian.

You may not qualify if:

  • Patients lacking one or more key outcome measures, including surgery duration, hospital stay, intraoperative blood loss, incidence of postoperative bile leakage, or incidence of postoperative intestinal obstruction.
  • Patients with incomplete clinical data, such as missing sex, age, or other essential demographic information.
  • Patients with coagulation disorders that may interfere with surgery or recovery.
  • Patients with severe comorbidities or immune system disorders that may complicate surgical intervention or recovery.
  • Patients who underwent non-surgical treatment (e.g., endoscopic procedures) for congenital choledochal cyst.
  • Pregnant patients or those who are breastfeeding (if applicable to your study population).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hansung University

Seoul, South Korea

Location

MeSH Terms

Conditions

Choledochal Cyst

Interventions

Conversion to Open SurgeryLaparoscopy

Condition Hierarchy (Ancestors)

CystsNeoplasmsBile Duct DiseasesBiliary Tract DiseasesDigestive System DiseasesDigestive System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

EndoscopyMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 27, 2024

First Posted

December 4, 2024

Study Start

January 1, 2010

Primary Completion

September 1, 2024

Study Completion

November 1, 2024

Last Updated

December 4, 2024

Record last verified: 2024-12

Locations